PER 1.41% 7.0¢ percheron therapeutics limited

the weeks ahead, page-14

  1. SRF
    1,046 Posts.
    Last week I emailed the Managing Director & CEO of Antisense Therapeutics Ltd, Mark Diamond,  to seek his comments  in regards to the list of anticipated announcements and the SP movements for the last few weeks.

    He replied today to confirm that the management is conscious about the issue of needs for follow up news flow. Annoucements will be made to the market when they are in a position to report.  Specific details such as timeline and plans cannot be disclosed selectively at this stage.

    From my pov, it is good to know that the management is not resting on their laurels but is working on the anticipated news flow at the moment.

    I am sure everything will fall into place in a timely manner.

    For the meantime, I welcome the opportunity to accumulate from those who cannot afford to hold.

    GLTA
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.